Al-madawah rehabilitation clinic
Lahore, Punjab Province, 6400, Pakistan
Location status: Recruiting
Location contact
faiqa Qayyum, MSPT(WH)
PRINCIPAL_INVESTIGATOR
hina gul
CONTACT
hina gul gul
CONTACT
NCT Number: NCT07576283
The study aims to compare the effectiveness of these two core training approaches in improving urinary incontinence, pelvic floor function, and quality of life in postpartum women.
Interested in participating?
Request Info18 year–35 year
Female
Interventional
Not applicable
Lahore, Punjab Province, 6400, Pakistan
Location status: Recruiting
faiqa Qayyum, MSPT(WH)
PRINCIPAL_INVESTIGATOR
hina gul
CONTACT
hina gul gul
CONTACT
The primary outcomes of this study are urinary incontinence, pelvic floor function, and quality of life in postpartum women. These outcomes will be assessed using validated instruments: the International Consultation on Incontinence Questionnaire-Urinary Incontinence (ICIQ-UI) for evaluating the severity of urinary incontinence, the King's Health Questionnaire (KHQ) for assessing the impact on pelvic floor function and health-related quality of life, and the Incontinence Impact Questionnaire (IIQ-7) for measuring the broader impact of incontinence on daily activities and emotional well-being. Outcome measures will be measured at baseline and after 4 weeks. Data analysis will be done by SPSS version 25.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Frequency: 3 sessions/week under supervision Duration: 30-40 minutes/session For 6 weeks
3 sessions/week under supervision Duration: 30-40 minutes/session For 6 weeks
Time frame: 6th week
The tool is used for assessing urinary incontinence symptoms by measuring the frequency, severity, and impact of urinary leakage on quality of life. It includes specific questions related to how often leakage occurs, the amount of urine lost, and how these symptoms affect various aspects of daily life, providing a comprehensive evaluation of the individual's condition
Time frame: 6th week
The tool is used for evaluating the impact of urinary incontinence on the quality of life in women, offering a comprehensive understanding of how stress urinary incontinence (SUI) affects their physical, emotional, and social well-being. It is particularly relevant for postpartum women, as it captures the functional limitations and lifestyle disruptions caused by incontinence, making it a valuable instrument for assessing the broader effects of SUI on daily life.
Time frame: 6th week
The Incontinence Impact Questionnaire (IIQ) is a validated self-report tool designed to measure the impact of urinary incontinence on a woman's quality of life across physical, social, and emotional domains.30 items divided into four domains:
Physical activity (6 items), Travel (6 items), Social relationships (10 items), Emotional health (8 items)
Contact information is provided by the study sponsor or research team.
Riphah International University
Other
Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Training on Urinary Incontinence, Pelvic Floor Function and Quality of Life in Postpartum
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07430865
Bowel Symptoms, Female Urogenital Diseases
Gothenburg, Sweden
View Trial DetailsNCT05009433
Anxiety, Anxiety Disorders
Gdansk, Pomeranian Voivodeship, Poland
View Trial DetailsNCT03254355
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Sherbrooke, Quebec, Canada
View Trial DetailsNCT07140211
Cardiovascular Diseases, Embolism and Thrombosis
Baden, Switzerland
View Trial Details